Repros Therapeutics is a biopharmaceutical company that specializes in the development of small molecule drugs for the diagnosis, treatment, and prevention of serious conditions affecting the safety and health of men and women.

History

Repros Therapeutics was founded in 1991 by Dr. Robert W. Clark who had a vision to develop innovative therapies focusing on male and female urological health. Since its founding, the company has grown to become an industry leader in the research and development of treatments for male and female urological conditions.

Mission

Repros Therapeutics strives to develop innovative therapeutic solutions that improve the lives of people affected by urological conditions.

Vision

To be a leader in the development of therapeutic solutions that improve the health and wellbeing of people affected by urological conditions.

Key Team

Joseph S. Podolski (Founder)

Recognition and Awards

Repros Therapeutics has received numerous awards including the American Association of Urologic Nurses and Associates Award of Excellence, the Drug Information Association's Annual Excellence in Clinical Research Award and the National Institutes of Health Award of Research Excellence.

References

https://in.investing.com/equities/repros-therapeutics

https://www.crunchbase.com/organization/repros-therapeutics

www.allergan.com/

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Leadership team

Joseph S. Podolski (Founder)

Products/ Services

Biopharma, Biotechnology, Pharmaceutical

Number of Employees

50 - 100

Headquarters

Houston, Texas, United States

Established

1987

Company Registration

SEC CIK number: 0001802768

Net Income

100M - 500M

Revenue

500M - 1B

Traded as

NASDAQ:RPRX

URL

www.allergan.com/

Last updated: Tue Feb 25 2025

We value your privacy

Repros Therapeutics

Table of content

Summary